Department of Medicine Archive — Page 59 of 127

Stylized human figure surrounded by colorful enlarged representations of bacteria and other microorganisms, illustrating the human microbiome.
March 14, 2022

Microbiome reflects COVID-19 severity

Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.

3D-rendered operating room with a multi-arm robotic surgical system above an operating table, flanked by two large surgical lights.
March 10, 2022

Bots boost liver cancer outcome

Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.

Silver medical-alert necklace with a tag labeled “PENICILLIN ALLERGY” and “SEE WALLET CARD,” alongside a medical emblem.
March 10, 2022

ICU study confirms safety of delabeling penicillin allergies

A Vanderbilt study shows that physicians can safely identify and disprove low-risk penicillin allergies using an oral amoxicillin challenge in consenting patients, even those in the intensive care unit who are recovering from critical illness.

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
March 7, 2022

Study finds World Trade Center responders at higher risk for blood cancer-associated mutations

A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease

Illustration of a human torso showing the heart and major blood vessels in red through a translucent rib cage and lungs.
March 3, 2022

Chest Pain Center receives reaccreditation from ACC

Vanderbilt University Medical Center has been reaccredited as a Chest Pain Center with Primary Percutaneous Coronary Intervention (PCI) and Resuscitation.

February 28, 2022

Invasive strep can defy zinc toxicity

Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.